Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group

Pooja Hingorani, Mark Krailo, Allen Buxton, Paul R. Hutson, Paul M. Sondel, Mitchell B. Diccianni, Alice L. Yu, Carol D. Morris, Richard B. Womer, Brian D. Crompton, R. Lor Randall, Lisa A. Teot, Steven G. DuBois, Katherine A. Janeway, Richard Görlick, Michael S. Isakoff